Last reviewed · How we verify

Dyclonine hydrochloride mucilage

Peking Union Medical College Hospital · FDA-approved active Small molecule

Dyclonine hydrochloride is a local anesthetic that blocks sodium channels in nerve cell membranes to prevent pain signal transmission.

Dyclonine hydrochloride is a local anesthetic that blocks sodium channels in nerve cell membranes to prevent pain signal transmission. Used for Topical anesthesia of oral and pharyngeal mucosa, Relief of pain and discomfort in the mouth and throat.

At a glance

Generic nameDyclonine hydrochloride mucilage
SponsorPeking Union Medical College Hospital
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaPain management / Otolaryngology
PhaseFDA-approved

Mechanism of action

Dyclonine is a topical local anesthetic that works by stabilizing the neuronal membrane and inhibiting the initiation and conduction of nerve impulses. When formulated as a mucilage, it provides prolonged contact with mucosal surfaces, allowing sustained local anesthetic effect for pain relief in the oral cavity and throat. The mucilage formulation enhances adhesion and duration of action compared to standard solutions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: